[1] WANG X, YUAN CX, XU B, et al. Diabetic foot ulcers: Classification, risk factors and management. World J Diabetes. 2022;13(12):1049-1065.
[2] 简喜超,邵靖杰,唐诗涵,等.外泌体促进糖尿病创面愈合:研究热点及演化趋势的可视化分析[J].中国组织工程研究,2026,30(19):5072-5081.
[3] EDMONDS M, MANU C, VAS P. The current burden of diabetic foot disease. J Clin Orthop Trauma. 2021;17:88-93.
[4] BURGESS JL, WYANT WA, ABDO ABUJAMRA B, et al. Diabetic Wound-Healing Science. Medicina (Kaunas). 2021;57(10):1072.
[5] SHANG J, CHENG L, OU Q. Tibial cortex transverse transport surgery to treat diabetic foot ulcerations: what mechanism is involved in accelerated wound healing? Int J Surg. 2025;111(2):2323-2324.
[6] ILIZAROV GA. The tension-stress effect on the genesis and growth of tissues. Part I. The influence of stability of fixation and soft-tissue preservation. Clin Orthop Relat Res. 1989;(238):249-281.
[7] LIU Z, XU C, YU YK, et al. Twenty Years Development of Tibial Cortex Transverse Transport Surgery in PR China. Orthop Surg. 2022;14(6):1034-1048.
[8] 李超,李娟,王栋,等.胫骨横向骨搬移重建糖尿病足微循环的研究进展[J].中华骨与关节外科杂志,2025,18(4):362-367.
[9] 冼呈,赵劲民,苏伟,等.外固定架骨搬移系统修复糖尿病足:功能与影像学评价[J].中国组织工程研究,2015,19(46):7539-7544.
[10] HU XX, XIU ZZ, LI GC, et al. Effectiveness of transverse tibial bone transport in treatment of diabetic foot ulcer: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023;13:1095361.
[11] 柏小金,徐林,刘福英,等.基于HIF-1α/VEGF信号通路探讨Ilizarov技术治疗糖尿病足溃疡的机制[J].中国老年学杂志,2023,43(21):5300-5303.
[12] HO PTB, CLARK IM, LE LTT. MicroRNA-Based Diagnosis and Therapy. Int J Mol Sci. 2022;23(13):7167.
[13] SHANG R, LEE S, SENAVIRATHNE G, et al. microRNAs in action: biogenesis, function and regulation. Nat Rev Genet. 2023;24(12):816-833.
[14] ZHAN C, LIU K, ZHANG Y, et al. Myocardial infarction unveiled: Key miRNA players screened by a novel lncRNA-miRNA-mRNA network model. Comput Biol Med. 2023;160:106987.
[15] 陈霞,商宇伟,王林晓,等.维生素D缺乏模型小鼠子宫转录组的测序分析[J].中国组织工程研究,2022,26(26):4101-4106.
[16] 涂明洋,李小磊,杨坚.自体PRP对糖尿病兔横向骨搬移术后局部血管再生及血管生长相关因子影响的实验研究[J].农垦医学,2024,46(6): 492-497.
[17] YANG Y, LI Y, PAN Q, et al. Tibial cortex transverse transport accelerates wound healing via enhanced angiogenesis and immunomodulation. Bone Joint Res. 2022;11(4):189-199.
[18] CHEN Y, CHEN L, LUN ATL, et al. edgeR v4: powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets. Nucleic Acids Res. 2025;53(2):gkaf018.
[19] BU D, LUO H, HUO P, et al. KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis. Nucleic Acids Res. 2021;49(W1):W317-W325.
[20] GARCÍA CORONADO PL, FRANCO MOLINA MA, ZÁRATE TRIVIÑO DG, et al. Exosomes isolated from IMMUNEPOTENT CRP, a hemoderivative, to accelerate diabetic wound healing. Front Bioeng Biotechnol. 2024; 12:1356028.
[21] 田林, 时孝晴,段正兰,等.胫骨横向骨搬移术治疗糖尿病足疗效及安全性的Meta分析[J].中国组织工程研究,2021,25(20):3275-3280.
[22] LIU N, DAI S, LIU D, et al. Application of Transverse Tibial Bone Transfer in Diabetic Foot Patients: A Comprehensive Evaluation of Postoperative Prognostic Factors and Risk Factors. Orthop Surg. 2025;17(9):2708-2716.
[23] XU D, BAI C, HU R, et al. Exploring the Changes in IL-6 and Related Cytokines in Angiogenesis after Tibial Transverse Transplantation in Diabetic Foot Ulcers. Orthop Surg. 2024;16(9):2181-2190.
[24] XIE J, LIU X, WU B, et al. Bone transport induces the release of factors with multi-tissue regenerative potential for diabetic wound healing in rats and patients. Cell Rep Med. 2024;5(6):101588.
[25] YU L, ZHANG D, YIN Y, et al. Tibial cortex transverse transport surgery improves wound healing in patients with severe type 2 DFUs by activating a systemic immune response: a cross-sectional study. Int J Surg. 2025; 111(1):257-272.
[26] QIN W, LIU K, SU H, et al. Tibial cortex transverse transport promotes ischemic diabetic foot ulcer healing via enhanced angiogenesis and inflammation modulation in a novel rat model. Eur J Med Res. 2024;29(1): 155.
[27] FANG Y, SUN S, WU J, et al. Alterations in the Levels of Urinary Exosomal MicroRNA-183-5p and MicroRNA-125a-5p in Individuals with Type 2 Diabetes Mellitus. Biomedicines. 2024;12(11):2608.
[28] XU Y, XU J, CHEN S, et al. Identifying potential pathogenesis and immune infiltration in diabetic foot ulcers using bioinformatics and in vitro analyses. BMC Med Genomics. 2023;16(1):313.
[29] ZHU L, ZHONG Q, YANG T, et al. Improved therapeutic effects on diabetic foot by human mesenchymal stem cells expressing MALAT1 as a sponge for microRNA-205-5p. Aging (Albany NY). 2019;11(24):12236-12245.
[30] YANG M, GU Y. LncRNA DLEU1 promotes angiogenesis in diabetic foot ulcer wound healing by regulating miR-96-5p. Ir J Med Sci. 2024;193(1):241-247.
[31] JIANG H, QIN H, YANG Q, et al. Effective delivery of miR-150-5p with nucleus pulposus cell-specific nanoparticles attenuates intervertebral disc degeneration. J Nanobiotechnology. 2024;22(1):292.
[32] SU X, LAI T, TAO Y, et al. miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis. Sci Rep. 2023;13(1):13587.
[33] HAO J, CHEN Y, YU Y. Circular RNA circ_0008360 Inhibits the Proliferation, Migration, and Inflammation and Promotes Apoptosis of Fibroblast-Like Synoviocytes by Regulating miR-135b-5p/HDAC4 Axis in Rheumatoid Arthritis. Inflammation. 2022;45(1):196-211.
[34] WU W, LI Q, ZHU Z, et al. HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway. Int J Biol Sci. 2022;18(9):3777-3794.
[35] FENG J, WANG Y, XIANG S, et al. Applying GC-MS based serum metabolomic profiling to characterize two traditional Chinese medicine subtypes of diabetic foot gangrene. Front Mol Biosci. 2024;11:1384307.
[36] DENG P, LIANG H, WANG S, et al. Combined metabolomics and network pharmacology to elucidate the mechanisms of Dracorhodin Perchlorate in treating diabetic foot ulcer rats. Front Pharmacol. 2022;13:1038656.
[37] XIAO Y, DONG X, CHEN C, et al. An integrated method for IgG N-glycans enrichment and analysis: Understanding the role of IgG glycosylation in diabetic foot ulcer. J Chromatogr B Analyt Technol Biomed Life Sci. 2024; 1233:123983.
[38] LYTRIVI M, SENÉE V, SALPEA P, et al. DNAJC3 deficiency induces β-cell mitochondrial apoptosis and causes syndromic young-onset diabetes. Eur J Endocrinol. 2021;184(3):455-468.
[39] ZHU Y, ZONG M, HU L, et al. USP7 deficiency promotes diabetic wound healing by repressing GATA3-mediated pro-inflammatory macrophage polarization. Mol Cell Endocrinol. 2025;599:112489.
[40] MOHAMMED SA, GORICA E, ALBIERO M, et al. Targeting SETD7 Rescues Diabetes-Induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin-3G. Diabetes. 2025;74(6):969-982.
[41] LIANG Z, ZHANG S, ZOU Z, et al. Functional characterization of BAG3 in orange-spotted grouper (Epinephelus coioides) during viral infection. Fish Shellfish Immunol. 2022;122:465-475.
[42] MARKUS T, LEY D, HANSSON SR, et al. Neuroprotective dobutamine treatment upregulates superoxide dismutase 3, anti-oxidant and survival genes and attenuates genes mediating inflammation. BMC Neurosci. 2018;19(1):9.
[43] HUANG Q, CHU X, YANG C, et al. Bio-engineered microRNA-7 effectively interferes with the Akt3/p53 axis to suppress human non-small cell lung cancer. Cancer Cell Int. 2025;25(1):250.
[44] HOU Q, YUAN J, LI S, et al. Autophagic degradation of DHCR7 activates AKT3 and promotes sevoflurane-induced hippocampal neuroinflammation in neonatal mice. Free Radic Biol Med. 2024;222:304-316.
[45] HERRERA JL, KOMATSU M. Akt3 activation by R-Ras in an endothelial cell enforces quiescence and barrier stability of neighboring endothelial cells via Jagged1. Cell Rep. 2024;43(3):113837.
[46] RAJA R, WU C, BASSOY EY, et al. PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling. J Immunother Cancer. 2022;10(12):e005026.
[47] LIAO FH, SHUI JW, HSING EW, et al. Protein phosphatase 4 is an essential positive regulator for Treg development, function, and protective gut immunity. Cell Biosci. 2014;4:25.
[48] CAO C, ZHOU S, HU J. Long noncoding RNA MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma. Int Forum Allergy Rhinol. 2020;10(8):1012-1023.
[49] FA X, SONG P, FU Y, et al. Long non-coding RNA VPS9D1-AS1 facilitates cell proliferation, migration and stemness in hepatocellular carcinoma. Cancer Cell Int. 2021;21(1):131.
[50] MORI S, KIMURA R, MORIHARA H, et al. Suppression of Dad1 induces cardiomyocyte death by weakening cell adhesion. Am J Physiol Cell Physiol. 2025;328(1):C95-C106.
|